V-Square Quantitative Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39K Buy
+162
New +$35.5K ﹤0.01% 614
2024
Q2
Sell
-680
Closed -$81.9K 593
2024
Q1
$81.9K Hold
680
0.01% 545
2023
Q4
$83.6K Buy
680
+265
+64% +$33.1K 0.01% 545
2023
Q3
$53.7K Buy
415
+64
+18% +$8.53K 0.02% 494
2023
Q2
$43.5K Buy
+351
New +$47.2K 0.03% 311

Other funds holding JAZZ

V-Square Quantitative Management's JAZZ Position: Q2 2026 in Review

V-Square Quantitative Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 162 shares worth $39K. The stake represents ﹤0.01% of the portfolio and ranks #614 among its holdings. This is a return to the name: V-Square Quantitative Management previously reported a position in JAZZ as recently as Q1 2024.

V-Square Quantitative Management first reported a position in JAZZ in Q2 2023 and has held it in 5 quarters since. The position peaked at $83.6K in Q4 2023. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • V-Square Quantitative Management held 162 shares of Jazz Pharmaceuticals worth $39K as of Q2 2026.
  • Jazz Pharmaceuticals was a new V-Square Quantitative Management position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of V-Square Quantitative Management's portfolio in Q2 2026, its #614 holding.
  • V-Square Quantitative Management first reported a position in Jazz Pharmaceuticals in Q2 2023 and has held it in 5 quarters since.
  • V-Square Quantitative Management's Jazz Pharmaceuticals position peaked at $83.6K in Q4 2023.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.